What to Know About the WHO’s New GLP-1 Drug Guideline

This Medical News article discusses key learnings from new World Health Organization guidance on the use of glucagon-like peptide-1 (GLP-1) medications for the treatment of obesity in adults.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-01-09
DOI
https://doi.org/10.1001/jama.2025.25208
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
30.73
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

What to Know About the WHO’s New GLP-1 Drug Guideline

Kate Schweitzer
1 citations
JAMA
Diabetes Treatment and Management
30.73
article

What to Know About the WHO’s New GLP-1 Drug Guideline

Kate Schweitzer
article en
1 citations

Abstract

This Medical News article discusses key learnings from new World Health Organization guidance on the use of glucagon-like peptide-1 (GLP-1) medications for the treatment of obesity in adults.

JAMAVol. 335(5)
ING Direct (US)
Good health and well-being
Openalex Percentile: Top 2%
Diabetes Treatment and Management
30.73
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

What to Know About the WHO’s New GLP-1 Drug Guideline — Kate Schweitzer · JAMA (2026) | TGRS Research Map | TGRS